It is no secret that the price tag to develop and successfully bring a new therapy to the marketplace is on the rise. According to a variety of sources research and development (R&D) expenditures to achieve product approval success can, depending on the therapy, run as high as $1.3 billion. Read More
Although the market to treat high cholesterol and high triglycerides is crowded with drugs, with plenty more in the later stages of clinical development, Catabasis Pharmaceuticals Inc. execs said the firm has a shot to compete despite its late start. The secret weapon: a two-pronged drug using its SMART-linker technology that can be delivered orally. Read More
Researchers at the Broad Institute have published an open access database, the Cancer Therapeutics Response Portal, which contains data on the effects of almost 200 small molecules on about 250 cancer cell lines. Read More
